DCF — ST BERNARDS MEDICAL CENTER
Enterprise Value: $-1.2B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.2B
Enterprise Value
$-356.1M
PV of Cash Flows
$-799.8M
PV of Terminal Value
$-1.3B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $438.1M | $-77.2M | -18.0% | $-95.8M | $-87.1M |
| Year 2 | $451.3M | $-75.0M | -17.0% | $-94.1M | $-77.8M |
| Year 3 | $464.8M | $-72.6M | -16.0% | $-92.3M | $-69.4M |
| Year 4 | $478.7M | $-72.4M | -15.0% | $-92.7M | $-63.3M |
| Year 5 | $493.1M | $-73.4M | -15.0% | $-94.2M | $-58.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.2B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$425.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.18130396195095713
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5